Rising healthcare costs, drug recalls [3] and a low public opinion [4] of the healthcare industry mean that there will be "less money in [direct-to-consumer advertising [5]]" and "more money in PR" in the future, predicts Chandler Chicco [6]'s Jeff Nesbit. Nesbit says the pharmaceutical industry is already "putting more resources into building alliances with third-party partners [7], particularly in the non-profit sector" and promoting "corporate social responsibility [8] programs." APCO Worldwide [9]'s Mike Tuffin warns, "Polls show that Americans are increasingly receptive to government in healthcare. ... You've got to help [industry] make a strong push about why the market-based approach is better."